 Hepatitis B virus
"Hepatitis B virus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum.
| Descriptor ID |
D006515
|
| MeSH Number(s) |
B04.280.375.650.425 B04.450.390.650.425 B04.909.204.340.650.425
|
| Concept/Terms |
Hepatitis B virus- Hepatitis B virus
- B virus, Hepatitis
- Hepatitis B viruses
- virus, Hepatitis B
- viruses, Hepatitis B
- Hepatitis Virus, Homologous Serum
|
Below are MeSH descriptors whose meaning is more general than "Hepatitis B virus".
Below are MeSH descriptors whose meaning is more specific than "Hepatitis B virus".
This graph shows the total number of publications written about "Hepatitis B virus" by people in this website by year, and whether "Hepatitis B virus" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1989 | 1 | 0 | 1 | | 1995 | 1 | 2 | 3 | | 1999 | 1 | 0 | 1 | | 2000 | 0 | 1 | 1 | | 2002 | 0 | 1 | 1 | | 2003 | 1 | 1 | 2 | | 2004 | 1 | 0 | 1 | | 2006 | 1 | 0 | 1 | | 2008 | 0 | 1 | 1 | | 2010 | 1 | 1 | 2 | | 2011 | 1 | 1 | 2 | | 2012 | 1 | 2 | 3 | | 2013 | 0 | 2 | 2 | | 2014 | 1 | 0 | 1 | | 2015 | 3 | 1 | 4 | | 2016 | 1 | 2 | 3 | | 2018 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Hepatitis B virus" by people in Profiles.
-
Artz AS, Paul S. Screening for Hepatitis B Virus Infection: Are We Asking the Right Questions? J Clin Oncol. 2018 04 01; 36(10):935-936.
-
Zhang L, Gui XE, Wang B, Fan JY, Cao Q, Mullane K, Liang XL. Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates. BMC Infect Dis. 2016 08 12; 16(1):408.
-
Julier Z, de Titta A, Grimm AJ, Simeoni E, Swartz MA, Hubbell JA. Fibronectin EDA and CpG synergize to enhance antigen-specific Th1 and cytotoxic responses. Vaccine. 2016 05 05; 34(21):2453-2459.
-
Paul S, Shuja A, Tam I, Kim EM, Kang S, Kapulsky L, Viveiros K, Lee H. Gastroenterologists Have Suboptimal Hepatitis B Virus Screening Rates in Patients Receiving Immunosuppressive Therapy. Dig Dis Sci. 2016 08; 61(8):2236-41.
-
Paul S, Saxena A, Terrin N, Viveiros K, Balk EM, Wong JB. Hepatitis B Virus Reactivation and Prophylaxis During Solid Tumor Chemotherapy: A Systematic Review and Meta-analysis. Ann Intern Med. 2016 Jan 05; 164(1):30-40.
-
Ahn J, Lee HM, Lim JK, Pan CQ, Nguyen MH, Ray Kim W, Mannalithara A, Trinh H, Chu D, Tran T, Min A, Do S, Te H, Reddy KR, Lok AS. Entecavir safety and effectiveness in a national cohort of treatment-naïve chronic hepatitis B patients in the US - the ENUMERATE study. Aliment Pharmacol Ther. 2016 Jan; 43(1):134-44.
-
Collins JM, Raphael KL, Terry C, Cartwright EJ, Pillai A, Anania FA, Farley MM. Hepatitis B Virus Reactivation During Successful Treatment of Hepatitis C Virus With Sofosbuvir and Simeprevir. Clin Infect Dis. 2015 Oct 15; 61(8):1304-6.
-
Hwang JP, Artz AS, Somerfield MR. Hepatitis B Virus Screening for Patients With Cancer Before Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update. J Oncol Pract. 2015 Jul; 11(4):e487-9.
-
Chan YK, Gack MU. RIG-I works double duty. Cell Host Microbe. 2015 Mar 11; 17(3):285-287.
-
Riedell P, Carson KR. A drug safety evaluation of rituximab and risk of hepatitis B. Expert Opin Drug Saf. 2014 Jul; 13(7):977-87.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|